THERAPEUTIC EFFICACY OF LACTOFERRIN LOADED ON NANO-PARTICLES IN TRICHINELLA SPIRALIS INFECTION IN MICE

Marwa Naguib, Azza El Hamshary, Ibrahim Baoumi, Azza M. Marei, Maha Fawzy, A. EL-GHANNAM
{"title":"THERAPEUTIC EFFICACY OF LACTOFERRIN LOADED ON NANO-PARTICLES IN TRICHINELLA SPIRALIS INFECTION IN MICE","authors":"Marwa Naguib, Azza El Hamshary, Ibrahim Baoumi, Azza M. Marei, Maha Fawzy, A. EL-GHANNAM","doi":"10.21608/jesp.2023.331737","DOIUrl":null,"url":null,"abstract":"Trichinellosis is a worldwide risky parasitic zoonosis caused by a nematode of the genus Trichinella . Anthelmintic such as albendazole and mebendazole commonly used to treat trichi-nellosis are badly water soluble and exhibit unfavorable bioavailability after oral administration increasing need for effective and safe drug. This study evaluated the therapeutic efficacy of lactoferrin loaded on silver nanoparticles in treating T. spiralis infection in mice by parasito-logical, immunological, and histopathological parameters. Forty albino mice were classified into 8 groups of 5 mice. G1: Non-infected non-treated (normal), (G2): Infected non-treated (infected control). G3: Infected and treated with albendazole, G4: Infected and treated with lactoferrin, G5: Infected and treated with silver nanoparticles, G6: Infected and treated with lactoferrin loaded on silver nanoparticles, G7: Infected and treated with albendazole in combination with lactoferrin, & G8: Infected and treated with albendazole in combination with lactoferrin loaded on silver nanoparticles. The results revealed a significant decline in all treated mice with the highest reduction rate of T. spiralis adult count in G8 treated with a combination of albendazole and lactoferrin loaded on silver nanoparticles (98.59%), followed by G7 treated with albendazole and lacto-ferrin (95.77%), G3 treated with albendazole (90.38%), G6 treated with lactoferrin loaded on silver nanoparticles (84.27%), G4 treated with lactoferrin (59.86%), and lowest reduction rate (22.3%) was in G5 treated with nanoparticles. Also, there was a significant decline in TNF-& IL-10 levels and an improvement of the intestinal histopathological changes in mice treated with a combination of albendazole and lactoferrin loaded on silver nanoparticles.","PeriodicalId":17289,"journal":{"name":"Journal of the Egyptian Society of Parasitology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Egyptian Society of Parasitology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/jesp.2023.331737","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Trichinellosis is a worldwide risky parasitic zoonosis caused by a nematode of the genus Trichinella . Anthelmintic such as albendazole and mebendazole commonly used to treat trichi-nellosis are badly water soluble and exhibit unfavorable bioavailability after oral administration increasing need for effective and safe drug. This study evaluated the therapeutic efficacy of lactoferrin loaded on silver nanoparticles in treating T. spiralis infection in mice by parasito-logical, immunological, and histopathological parameters. Forty albino mice were classified into 8 groups of 5 mice. G1: Non-infected non-treated (normal), (G2): Infected non-treated (infected control). G3: Infected and treated with albendazole, G4: Infected and treated with lactoferrin, G5: Infected and treated with silver nanoparticles, G6: Infected and treated with lactoferrin loaded on silver nanoparticles, G7: Infected and treated with albendazole in combination with lactoferrin, & G8: Infected and treated with albendazole in combination with lactoferrin loaded on silver nanoparticles. The results revealed a significant decline in all treated mice with the highest reduction rate of T. spiralis adult count in G8 treated with a combination of albendazole and lactoferrin loaded on silver nanoparticles (98.59%), followed by G7 treated with albendazole and lacto-ferrin (95.77%), G3 treated with albendazole (90.38%), G6 treated with lactoferrin loaded on silver nanoparticles (84.27%), G4 treated with lactoferrin (59.86%), and lowest reduction rate (22.3%) was in G5 treated with nanoparticles. Also, there was a significant decline in TNF-& IL-10 levels and an improvement of the intestinal histopathological changes in mice treated with a combination of albendazole and lactoferrin loaded on silver nanoparticles.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
纳米颗粒上的乳铁蛋白对小鼠旋毛虫感染的疗效
毛滴虫病是一种由毛滴虫属线虫引起的世界性风险寄生虫病。常用于治疗旋毛虫病的阿苯达唑和甲苯达唑等抗寄生虫药水溶性差,口服后生物利用度低,因此需要更有效、更安全的药物。本研究通过寄生虫逻辑学、免疫学和组织病理学参数,评估了银纳米颗粒上负载的乳铁蛋白治疗小鼠螺旋体感染的疗效。40 只白化小鼠被分为 8 组,每组 5 只。G1:未感染未处理(正常),(G2):感染后未处理(感染对照组)。G3:感染并用阿苯达唑治疗;G4:感染并用乳铁蛋白治疗;G5:感染并用纳米银颗粒治疗;G6:感染并用负载在纳米银颗粒上的乳铁蛋白治疗;G7:感染并用阿苯达唑联合乳铁蛋白治疗;G8:感染并用阿苯达唑联合负载在纳米银颗粒上的乳铁蛋白治疗。结果显示,所有治疗小鼠的螺旋体成虫数量都有明显下降,其中使用阿苯达唑和负载在银纳米粒子上的乳铁蛋白联合治疗的 G8 的螺旋体成虫数量下降率最高(98.59%),其次是使用阿苯达唑和乳铁蛋白治疗的 G7(95.其次是用阿苯达唑和乳铁蛋白处理的 G7(95.77%)、用阿苯达唑处理的 G3(90.38%)、用负载在银纳米粒子上的乳铁蛋白处理的 G6(84.27%)、用乳铁蛋白处理的 G4(59.86%),而用纳米粒子处理的 G5 降低率最低(22.3%)。此外,用阿苯达唑和负载在银纳米粒子上的乳铁蛋白组合治疗小鼠,TNF-和IL-10水平明显下降,肠道组织病理学变化也有所改善。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
THERAPEUTIC EFFICACY OF LACTOFERRIN LOADED ON NANO-PARTICLES IN TRICHINELLA SPIRALIS INFECTION IN MICE EFFECTS OF INTRAMUSCULAR INJECTION OF PLATELET-RICH PLASMA ON LARVAL BURDEN OF TRICHINELLA SPIRALIS IN EXPERIMENTALLY INFECTED MICE HUMAN LICE INFESTATION, DIAGNOSIS AND TREATMENT: A MINI-REVIEW COMPARISON BETWEEN GROWTH MAGNITUDE OF BLASTOCYSTIS GENOTYPES ISOLATED FROM GASTROINTESTINAL SYMPTOMATIC EGYPTIAN PATIENTS CAPILLARIA PHILIPPINENSIS IDENTIFIED IN DIARRHEIC PATIENTS FROM BENI-SUEF UNIVERSITY HOSPITALS, EGYPT
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1